Facebook Twitter LinkedIn Google Plus RSS

Cyclacel Pharmaceuticals announces $10M underwritten offering

By ,

Berkeley Heights-based Cyclacel Pharmaceuticals Inc. announced Friday the pricing of its public offering of 2.857 million shares of common stock at a price of $3.50 per share.

According to the announcement, the company expects to receive approximately $10 million from the offering.

Cyclacel has granted underwriters a 30-day option to purchase up to an additional 428,571 shares of stock.  Laidlaw & Company Ltd. is the sole bookrunning manager for the offering, the company said in a recent press release.


Most-read April 3: Meadowlands Hospital Medical Center names new CEO

EDA to begin offering N.J. entrepreneurs one-on-one access to investors

Bergman, Time Equities lease Cherry Hill office space to G.S.A.

Also Popular on NJBIZ

Emily Bader

Emily Bader

Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy